MyProstateScore in men considering repeat biopsy: validation of a simple testing approach

BACKGROUND: Men with persistent risk of Grade Group (GG) ≥ 2 cancer after a negative biopsy present a unique clinical challenge. The validated MyProstateScore test is clinically-available for pre-biopsy risk stratification. In biopsy-naïve patients, we recently validated a straightforward testing ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosoian, Jeffrey J., Sessine, Michael S., Trock, Bruce J., Ross, Ashley E., Xie, Cassie, Zheng, Yingye, Samora, Nathan L., Siddiqui, Javed, Niknafs, Yashar, Chopra, Zoey, Tomlins, Scott, Kunju, Lakshmi P., Palapattu, Ganesh S., Morgan, Todd M., Wei, John T., Salami, Simpa S., Chinnaiyan, Arul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310885/
https://www.ncbi.nlm.nih.gov/pubmed/36585434
http://dx.doi.org/10.1038/s41391-022-00633-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310885/
https://www.ncbi.nlm.nih.gov/pubmed/36585434
http://dx.doi.org/10.1038/s41391-022-00633-3

Ejemplares similares